// App-Quantinova.ai

4960 : Molecular characterization of in-vivo isolated EpCAM-positive circulating tumor cells in high-risk prostate cancer patients

Researchers

Presenter

  • Athina N. Markou

Principal Investigators

  • Marifili Lazaridou

  • Panagiotis Paraskevopoulos

  • Shukun Chen

  • Thomas Kroneis

  • Monika Swierczewska

  • Joanna Budna

  • Andra Kuske

  • Tobias M. Gorges

  • Maciej Zabel

  • Peter Sedlmayr

  • Catherine Alix-Panabieres

  • Klaus Pantel

  • Evi S. Lianidou

Medical Centers

  • Analysis of Circulating Tumor Cells Laboratory, Dept of Chemistry, Univ. of Athens, Athens, Greece

  • Institute for Cell Biology, Histology and Embryology, Center of Molecular Medicine, Medical University of Graz, Graz, Austria

  • Department of Histology and Embryology, Poznan University of Medical Sciences, Poznan, Poland

  • Institute of Tumor Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  • University Institute for Clinical Research (IURC), Laboratory of Rare Human Circulating Cells, University Medical Centre of Montpellier Saint-Eloi Hospital, EA , Montpellier, France.

Locations

  • Greece

  • Austria

  • Poland

  • Germany

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Aldehyde dehydrogenase 1

  • beta-2 microglobulin

  • Plastin-3

  • Circulating tumor cells

  • Prominin 1

  • Prostate specific antigen

  • Prostate Stem Cell Antigen

  • Cytokeratin 19

  • Solute Carrier Family 22 Member 3

  • Twist-related protein 1

  • Vimentin

Drug/Treatment

  • rAAV2/5-PBGD

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved